suisen ad us. vet. injektionssuspension für schweine
dr. e. gräub ag - escherichia (e.) coli, fimbrial adhesin f4ab, escherichia (e.) coli fimbrial adhesin f4ac, escherichia (e.) coli fimbrial adhesin f5, escherichia (e.) coli fimbrial adhesin f6, escherichia (e.) coli, lt-enterotoxoid, clostridium perfringens type c, toxoid, clostridium novyi type b, toxoid - injektionssuspension für schweine - escherichia (e.) coli, fimbrial adhesin f4ab ≥ 65 u., escherichia (e.) coli fimbrial adhesin f4ac ≥ 78 u., escherichia (e.) coli fimbrial adhesin f5 ≥ 79 u., escherichia (e.) coli fimbrial adhesin f6 ≥ 80 u., escherichia (e.) coli, lt-enterotoxoid ≥ 55 u., clostridium perfringens type c, toxoid ≥ 35 u., clostridium novyi type b, toxoid ≥ 50 u., aluminii hydroxidatum gelatum 0.5 g, ginseng extractum, alcohol benzylicus, simeticonum, dinatrii phosphas, natrii dihydrogenophosphas, natrii chloridum, ad suspensionem pro dosi 2 ml. - inaktivierter bakterieller impfstoff gegen e. coli und clostridum toxoid bei schweinen - impfstoffe
enteroporc ac lyophilisat und lösungsmittel zur herstellung einer injektionssuspension
idt biologika - clostridium perfringens type a/c, alfa-toxoid; clostridium perfringens type a/c, beta1 toxoid; clostridium perfringens type a/c, beta2 toxoid - lyophilisat und lösungsmittel zur herstellung einer injektionssuspension - clostridium perfringens type a/c, alfa-toxoid; clostridium perfringens type a/c, beta1 toxoid; clostridium perfringens type a/c, beta2 toxoid - clostridium - schwein
enteroporc ac lyophilisat und lösungsmittel zur herstellung einer injektionssuspension
idt biologika - clostridium perfringens type a/c, alfa-toxoid; clostridium perfringens type a/c, beta1 toxoid; clostridium perfringens type a/c, beta2 toxoid - lyophilisat und lösungsmittel zur herstellung einer injektionssuspension - clostridium perfringens type a/c, alfa-toxoid; clostridium perfringens type a/c, beta1 toxoid; clostridium perfringens type a/c, beta2 toxoid - clostridium - schwein
bravoxin injektionssuspension
intervet international - clostridium novyi-toxoid; clostridium tetani-toxoid; clostridium haemolyticum-toxoid; clostridium sordellii-toxoid; clostridium perfringens type a, α toxoid; clostridium perfringens type b,c (beta) toxoid; clostridium perfringens type d (epsilon) toxoid; clostridium chauvoei; clostridium septicum - injektionssuspension - clostridium novyi-toxoid ; clostridium tetani-toxoid ; clostridium haemolyticum-toxoid ; clostridium sordellii-toxoid ; clostridium perfringens type a, α toxoid ; clostridium perfringens type b,c (beta) toxoid ; clostridium perfringens type d (epsilon) toxoid ; clostridium chauvoei ; clostridium septicum - clostridium; clostridium - rind; schaf
gletvax 6
zoetis deutschland gmbh (4402304) - clostridium-perfringens-typ-b-beta-toxoid; clostridium-perfringens-typ-c-beta-toxoid; clostridium-perfringens-epsilon-antitoxin für tiere; escherichia coli, fimbrien-adhäsin 4ab / kapselantigen 88, inaktiviert; escherichia coli, fimbrien-adhäsin 4ac / kapselantigen 88, inaktiviert; escherichia coli, fimbrien-adhäsin f5; escherichia coli, fimbrien-adhäsin f6 - injektionssuspension - clostridium-perfringens-typ-b-beta-toxoid (14028) 300 internationale einheit; clostridium-perfringens-typ-c-beta-toxoid (14030) 300 internationale einheit; clostridium-perfringens-epsilon-antitoxin für tiere (05274) 200 internationale einheit; escherichia coli, fimbrien-adhäsin 4ab / kapselantigen 88, inaktiviert (35460) 3,8679 allergen-einheit; escherichia coli, fimbrien-adhäsin 4ac / kapselantigen 88, inaktiviert (35461) 3,9542 allergen-einheit; escherichia coli, fimbrien-adhäsin f5 (35462) 3,6088 allergen-einheit; escherichia coli, fimbrien-adhäsin f6 (35463) 3,7115 allergen-einheit - zuchtsau
covexin 8
zoetis deutschland gmbh (4402304) - clostridium-perfringens-typ-b-beta-toxoid; clostridium-perfringens-typ-c-beta-toxoid; clostridium perfringens typ d epsilon toxoid; clostridium chauvoei vollkultur; clostridium-novyi-toxoid; clostridium-septicum-toxoid, inaktiviert; tetanus-toxoid, adsorbiert; clostridium-haemolyticum-toxoid - injektionssuspension - clostridium-perfringens-typ-b-beta-toxoid (14028) 10 internationale einheit; clostridium-perfringens-typ-c-beta-toxoid (14030) 10 internationale einheit; clostridium perfringens typ d epsilon toxoid (38431) 5 internationale einheit; clostridium chauvoei vollkultur (38432) 5 internationale einheit; clostridium-novyi-toxoid (14031) 3,5 internationale einheit; clostridium-septicum-toxoid, inaktiviert (35438) 2,5 internationale einheit; tetanus-toxoid, adsorbiert (30976) 2,5 internationale einheit; clostridium-haemolyticum-toxoid (14032) 10 internationale einheit - schwein; rind; schaf
covexin zehn
zoetis deutschland gmbh (4402304) - clostridium chauvoei vollkultur; clostridium-perfringens-typ-b&c-beta-toxoid; clostridium perfringens typ d epsilon toxoid; clostridium-novyi-toxoid; clostridium-septicum-toxoid, inaktiviert; tetanus-toxoid, adsorbiert; clostridium-sordellii-toxoid; clostridium-haemolyticum-toxoid; clostridium-perfringens-typ-a-toxoid - injektionssuspension - clostridium chauvoei vollkultur (38432) 90 prozent schutz; clostridium-perfringens-typ-b&c-beta-toxoid (38636) 12,4 elisa-einheit; clostridium perfringens typ d epsilon toxoid (38431) 5,1 elisa-einheit; clostridium-novyi-toxoid (14031) 1,2 elisa-einheit; clostridium-septicum-toxoid, inaktiviert (35438) 3,6 elisa-einheit; tetanus-toxoid, adsorbiert (30976) 2,5 elisa-einheit; clostridium-sordellii-toxoid (35000) 0,8 elisa-einheit; clostridium-haemolyticum-toxoid (14032) 16,5 elisa-einheit; clostridium-perfringens-typ-a-toxoid (35001) 0,9 elisa-einheit - schaf; rind
enteroporc coli ac
ceva santé animale - clostridium perfringens type c, beta1 toxoid / clostridium perfringens, type a, alpha toxoid / clostridium perfringens, type a, beta2 toxoid / escherichia coli, fimbrial adhesin f4ab / escherichia coli, fimbrial adhesin f4ac / escherichia coli, fimbrial adhesin f5 / escherichia coli, fimbrial adhesin f6 - immunologicals for suidae, inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) escherichia + clostridium - schweine - for the passive immunisation of progeny by active immunisation of pregnant sows and gilts to reduce:- clinical signs (severe diarrhoea) and mortality caused by escherichia coli strains expressing the fimbrial adhesins f4ab, f4ac, f5 and f6- clinical signs (diarrhoea during the first days of life) associated with clostridium perfringens type a expressing alpha and beta 2 toxins- clinical signs and mortality associated with haemorrhagic and necrotising enteritis caused by clostridium perfringens type c expressing beta1 toxin.
entericolix ad us. vet. emulsion zur injektion für schweine
boehringer ingelheim (schweiz) gmbh - escherichia (e.) coli, strain p4, f6 adhesins, inactivated, escherichia (e.) coli, strain p5, f18ab adhesins, inactivated, escherichia (e.) coli, strain p6, f4ac adhesins, inactivated, escherichia (e.) coli, strain p9, f18ac adhesins, inactivated, escherichia (e.) coli, strain p10, f5+f41 adhesins, inactivated, beta-toxoid of clostridium perfringens, type c (czv13) - emulsion zur injektion für schweine - escherichia (e.) coli, strain p4, f6 adhesins, inactivated ≥ 1 u., escherichia (e.) coli, strain p5, f18ab adhesins, inactivated ≥ 1 u., escherichia (e.) coli, strain p6, f4ac adhesins, inactivated ≥ 1 u., escherichia (e.) coli, strain p9, f18ac adhesins, inactivated ≥ 1 u., escherichia (e.) coli, strain p10, f5+f41 adhesins, inactivated ≥ 1 u., beta-toxoid of clostridium perfringens, type c (czv13) ≥ 10 u., paraffinum perliquidum 0.76 ml, montanide 0.0425 ml, sorbitani oleas 0.0425 ml, thiomersalum 0.2 mg, dinatrii phosphas, formaldehydum, polysorbatum 80, kalii hydrogenophosphas, natrii chloridum, aqua ad iniectabile, ad emulsionem pro dosi 2 ml. - inaktivierter bakterieller impfstoff gegen e.coli und clostridium perfringens bei schweinen - impfstoffe
enteroporc coli ac ad us. vet. lyophilisat et suspension pour préparation une suspension injectable pour porcs
biokema s.a. - clostridium (c.) perfringens type a alpha toxoid, clostridium (c.) perfringens type a beta2 toxoid, clostridium (c.) perfringens type c beta1 toxoid, escherichia (e.) coli, fimbrial adhesins, inactivated, f4ab (k88ab), escherichia (e.) coli, fimbrial adhesins, inactivated, f4ac (k88ac), escherichia (e.) coli, fimbrial adhesins, inactivated, f5 (k99), escherichia (e.) coli, fimbrial adhesins, inactivated, f6 (987p) - lyophilisat et suspension pour préparation une suspension injectable pour porcs - praeparatio cryodesiccata: clostridium (c.) perfringens type a alpha toxoid ≥ 125 u., clostridium (c.) perfringens type a beta2 toxoid ≥ 794 u., clostridium (c.) perfringens type c beta1 toxoid ≥ 3354 u., saccharum, pro dosi. suspension: escherichia (e.) coli, fimbrial adhesins, inactivated, f4ab (k88ab) ≥ 23 u., escherichia (e.) coli, fimbrial adhesins, inactivated, f4ac (k88ac) ≥ 19 u., escherichia (e.) coli, fimbrial adhesins, inactivated, f5 (k99) ≥ 13 u., escherichia (e.) coli, fimbrial adhesins, inactivated, f6 (987p) ≥ 37 u., aluminii oxidum hydricum 2 mg/ml, natrii chloridum, dinatrii phosphas dihydricus, kalii dihydrogenophosphas, aqua ad iniectabile, ad suspensionem pro dosi 2 ml. - vaccin bactérien inactivé contre e. coli et les toxoïdes de clostridium chez les porcs - impfstoffe